Terms: = Sarcomas AND ERBB2, c-erb B2, 2064, P04626, ENSG00000141736, c-erbB2, HER-2/neu, HER2, TKR1, NEU, NGL, HER-2 AND Diagnosis
84 results:
1. [Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion].
Wang WN; Liu XT; Liang YM
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
[No Abstract] [Full Text] [Related]
2. Risk-adjusted benchmarking of long-term overall survival in patients with her2-positive early-stage Breast cancer: A Swedish retrospective cohort study.
Thurell J; Manouchehri N; Fredriksson I; Wilking U; Bergh J; Ryden L; Koppert LB; Karsten MM; Kiani NA; Hedayati E
Breast; 2023 Aug; 70():18-24. PubMed ID: 37295176
[TBL] [Abstract] [Full Text] [Related]
3. Clinically Aggressive Uterine Epithelioid Leiomyosarcoma with Rhabdomyoblastic Differentiation and High Proliferation Rate: A Case Report.
Kim JY; Kim B
Am J Case Rep; 2023 May; 24():e939349. PubMed ID: 37190674
[TBL] [Abstract] [Full Text] [Related]
4. Comprehensive genomic profiling of a unique liposarcoma arising in a patient with Li-Fraumeni syndrome and the novel detection of c-myc amplification: a case report.
Watanabe H; Fujishima F; Motoi T; Aoyama Y; Niihori T; Takahashi M; Umegaki S; Oishi H; Tada H; Ichinohasama R; Sasano H
Diagn Pathol; 2022 Dec; 17(1):93. PubMed ID: 36514176
[TBL] [Abstract] [Full Text] [Related]
5. Next-generation sequencing in breast pathology: real impact on routine practice over a decade since its introduction.
Nourieh M; Vibert R; Saint-Ghislain M; Cyrta J; Vincent-Salomon A
Histopathology; 2023 Jan; 82(1):162-169. PubMed ID: 36482269
[TBL] [Abstract] [Full Text] [Related]
6. Portuguese Consensus Recommendations for Next-Generation Sequencing of Lung Cancer, Rare Tumors, and Cancers of Unknown Primary Origin in Clinical Practice.
R Teixeira M; Oliveira J; Borralho P; O Fernandes MG; Almodovar T; Fernandes I; Macedo D; Ferreira A; Barroso A; Teixeira E; Machado JC
Acta Med Port; 2022 Sep; 35(9):677-690. PubMed ID: 35816050
[TBL] [Abstract] [Full Text] [Related]
7. Application of first-order feature analysis of DWI-ADC in rare malignant mesenchymal tumours of the maxillofacial region.
Yu B; Huang C; Liu S; Li T; Guan Y; Zheng X; Ding J
BMC Oral Health; 2021 Sep; 21(1):463. PubMed ID: 34556116
[TBL] [Abstract] [Full Text] [Related]
8. Yolk Sac Tumor Arising in Uterine Carcinosarcoma With Endometrioid and Serous Components: A Case Report With Immunohistochemical Analysis.
Grindstaff S; Hanley LC; Banet N
Int J Gynecol Pathol; 2022 Jan; 41(1):40-44. PubMed ID: 33770060
[TBL] [Abstract] [Full Text] [Related]
9. The mutational repertoire of uterine sarcomas and carcinosarcomas in a Brazilian cohort: A preliminary study.
da Costa LT; Dos Anjos LG; Kagohara LT; Torrezan GT; De Paula CAA; Baracat EC; Carraro DM; Carvalho KC
Clinics (Sao Paulo); 2021; 76():e2324. PubMed ID: 33503190
[TBL] [Abstract] [Full Text] [Related]
10.
Jaraj D; Höijer J; Widman L; Ahlgren J; Arnesson LG; Einbeigi Z; Klintman M; Vikhe Patil E; Sund M; Fredriksson I; Bergh J; Andreas P
JNCI Cancer Spectr; 2021 Feb; 5(1):. PubMed ID: 33442658
[TBL] [Abstract] [Full Text] [Related]
11. Non-human-papillomavirus-related malignancies of the vulva: A clinicopathological study.
Furlan K; Rohra P; Mir F; Gattuso P
J Cutan Pathol; 2020 Oct; 47(10):917-922. PubMed ID: 32511773
[TBL] [Abstract] [Full Text] [Related]
12. Use of Fluorescence In Situ Hybridization (FISH) in diagnosis and Tailored Therapies in Solid Tumors.
Chrzanowska NM; Kowalewski J; Lewandowska MA
Molecules; 2020 Apr; 25(8):. PubMed ID: 32316657
[TBL] [Abstract] [Full Text] [Related]
13. Frequency of radiation-induced malignancies post-adjuvant radiotherapy for breast cancer in patients with Li-Fraumeni syndrome.
Le AN; Harton J; Desai H; Powers J; Zelley K; Bradbury AR; Nathanson KL; Shah PD; Doucette A; Freedman GM; Gabriel P; Domchek SM; MacFarland SP; Maxwell KN
Breast Cancer Res Treat; 2020 May; 181(1):181-188. PubMed ID: 32246378
[TBL] [Abstract] [Full Text] [Related]
14. Radiotherapy-induced malignancies in breast cancer patients with TP53 pathogenic germline variants (Li-Fraumeni syndrome).
Petry V; Bonadio RC; Cagnacci AQC; Senna LAL; Campos RDNG; Cotti GC; Hoff PM; Fragoso MCBV; Estevez-Diz MDP
Fam Cancer; 2020 Jan; 19(1):47-53. PubMed ID: 31748977
[TBL] [Abstract] [Full Text] [Related]
15. Osteosarcoma and second malignant neoplasms: a case series.
Geary RL; Corrigan LR; Carney DN; Higgins MJ
Ir J Med Sci; 2019 Nov; 188(4):1163-1167. PubMed ID: 31054046
[TBL] [Abstract] [Full Text] [Related]
16. Primary Epithelioid Angiosarcoma of the Breast: A Rare and Challenging Biopsy diagnosis.
Mendoza R; Loukeris K
Am J Case Rep; 2019 Apr; 20():437-440. PubMed ID: 30940796
[TBL] [Abstract] [Full Text] [Related]
17. The levels of bone alkaline phosphatase (BALP) and soluble epidermal growth factor receptor-2 (ECD/her-2) in pediatric patients with osteosarcoma during clinical treatment.
Rychłowska-Pruszyńska M; Gajewska J; Ambroszkiewicz J; Karwacki M; Szamotulska K
Dev Period Med; 2018; 22(1):58-64. PubMed ID: 29641422
[TBL] [Abstract] [Full Text] [Related]
18. The Clinicopathological Study of 21 Cases With Uterine Smooth Muscle Tumors of Uncertain Malignant Potential: Centralized Review Can Purify the diagnosis.
Basaran D; Usubutun A; Salman MC; Narin MA; Boyraz G; Turkmen O; Comert Kimyon G; Karalok A; Bulbul D; Turan T; Ozgul N; Yuce K
Int J Gynecol Cancer; 2018 Feb; 28(2):233-240. PubMed ID: 29303932
[TBL] [Abstract] [Full Text] [Related]
19. Population-level effect of molecular testing and targeted therapy in patients with advanced pulmonary adenocarcinoma: a prospective cohort study.
Schwegler C; Kaufmann D; Pfeiffer D; Aebi S; Diebold J; Gautschi O
Virchows Arch; 2018 Apr; 472(4):581-588. PubMed ID: 29198034
[TBL] [Abstract] [Full Text] [Related]
20. Clinical implications of germline mutations in breast cancer: TP53.
Schon K; Tischkowitz M
Breast Cancer Res Treat; 2018 Jan; 167(2):417-423. PubMed ID: 29039119
[TBL] [Abstract] [Full Text] [Related]
[Next]
